\
&
Contact us
This was 4 years ago
Locationvirtual
ProgrammesThe Big Science Business Forum is organised by 11 European Research Infrastructures (RIs) focused on technology. By organising a business oriented congress they aim to create a meeting point between RIs and industry. The second edition is postponed due to the coronavirus pandemic to 4-7 October 2022. In the run-up to the conference a webinar series is organised on the topic ‘A look into the future of Big Science infrastructures.’
Miniseries Episode #1: Strategic view, roadmaps and development programmes of astronomy research infrastructures
Miniseries Episode #2: Fusion: Strategies, roadmaps and development programmes
Miniseries Episode #3: High-Energy Accelerators and Synchrotrons: strategies, roadmaps and development programmes
All information on the webinars can be found on this webpage
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Health AI Continent Deployment: Best use of technologies
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.